[{"Assets_0_Q3_USD":126525000.0,"CommonStockSharesOutstanding_0_Q3_shares":17247306.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-25854000.0,"NetIncomeLoss_1_Q3_USD":-3956000.0,"NetIncomeLoss_3_Q3_USD":-12290000.0,"StockholdersEquity_0_Q3_USD":104033000.0,"Ticker":"KALV","CIK":"1348911","name":"KALVISTA PHARMACEUTICALS, INC.","OfficialName":"KalVista Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190131","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339433230.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190314"}]